Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Bone. 2016 Aug 31;92:150–156. doi: 10.1016/j.bone.2016.08.025

Figure 5.

Figure 5

Bone mineral density (BMD) of the lumbar spine and left femoral neck obtained prior to (October 2013) and following therapy with 5 doses of denosumab, 60 mg given subcutaneously every 6 months through October 2015 in a subject with HCS. Note that scale for y-axis for lumbar and femoral neck BMD is different.